Photoactivatable carbon monoxide-releasing molecules enhance targeted CO delivery, indicating potential therapeutic uses.
Carbon monoxide (CO) is a well-established gasotransmitter known for its diverse physiological benefits. However, achieving controlled and targeted CO delivery remains challenging. To address this, light-activated carbon monoxide-releasing molecules (photoCORMs)...
No takes yet. Share an insight, caveat, or question.
M et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: